SCHEMBL6894849

SCHEMBL6894849

CCCN(CCC)C(=O)c1cc(C(N)=O)cc(C(=O)N(CCC)CCC)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MLYCD O95822 1/20 0.49
TP53 P04637 1/20 0.48
HPGD P15428 2/20 0.47
EGFR P00533 2/20 0.46
ERBB2 P04626 2/20 0.46
GABRA1 P14867 1/20 0.43
GABRB2 P47870 1/20 0.43
BACE1 P56817 5/20 0.41
CTSD P07339 3/20 0.41
TSHR P16473 2/20 0.41
NTRK2 Q16620 1/20 0.39
LMNA P02545 1/20 0.39
RECQL P46063 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
CA12 O43570 1/20 0.38
CA2 P00918 1/20 0.38
CA9 Q16790 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2D6 P10635 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3352714 1.00 MLYCD (0.49) MLYCDTP53HPGDEGFRERBB2
SCHEMBL6139506 0.93 MLYCD (0.44) MLYCDTP53HPGDEGFRERBB2
SCHEMBL5130313 0.93 MLYCD (0.44) MLYCDTP53HPGDEGFRERBB2
SCHEMBL3349246 0.89 KDM4E (0.45) MLYCDTP53HPGDEGFRERBB2
SCHEMBL6886635 0.86 MLYCD (0.39) MLYCDTP53HPGDEGFRERBB2
SCHEMBL7055563 0.86 DHODH (0.56) MLYCDTP53HPGDGABRA1GABRB2
SCHEMBL2206850 0.86 TP53 (0.51) MLYCDTP53HPGDEGFRERBB2
SCHEMBL6894254 0.85 MLYCD (0.38) MLYCDTP53HPGDEGFRERBB2
SCHEMBL3355469 0.85 TP53 (0.41) MLYCDTP53HPGDEGFRERBB2
SCHEMBL28278838 0.85 MLYCD (0.62) MLYCDTP53HPGDEGFRERBB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-2004502669-A 2004-01-29 JP claimed
EP-1353898-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2003-10-22 EP claimed
WO-2002002512-A2 COMPOUNDS TO TREAT ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-01-10 WO claimed